What are the consequences of failing to meet accelerated examination requirements?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Failing to meet the accelerated examination requirements can have significant…

Read More

How does the USPTO handle applications related to ‘recombinant DNA’ inventions?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The USPTO gives special attention to patent applications involving recombinant…

Read More

What are the criteria for patent applications involving HIV/AIDS or cancer to receive special status?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Patent applications related to HIV/AIDS or cancer can receive special…

Read More

What are the benefits of participating in the Patent Prosecution Highway (PPH) program?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-10 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The Patent Prosecution Highway (PPH) program offers several benefits to…

Read More